Suresh Kumar*, Rameshwar Dass.
Abstract:
India has a rich heritage of traditional medicines which has been flourishing since from very long time. With the ever-increasing use of herbal medicines worldwide and the rapid expansion of the global market for these products, the safety and quality of medicinal plant materials and finished herbal medicinal products have become a major concern for health authorities, pharmaceutical industries and the public. In the present study several pharmaceutical standardization parameters of three commercial available Ayurvedic polyherbal formulations i.e. Ashwaganda churna (Aswajith), Ashwaganda lehya (Ashwagandhadi Lehyam) and Ashwaganda arista (Ashwagandharistam) are discussed. In addition, the estimation of active constituents of Ashwagandha particularly withanolide-A and withaferin-A in all three formulations was carried out using HPTLC.